1977
DOI: 10.1007/978-3-642-66639-1_20
|View full text |Cite
|
Sign up to set email alerts
|

Prolymphocytic Leukemia with T Cell Properties and Tartrate Resistant Acid Phosphatase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
4
0

Year Published

1978
1978
1987
1987

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 8 publications
3
4
0
Order By: Relevance
“…These results seem to indicate that T-rAcP is observed in well-differentiated lymphoid cells except the most highly differentiated forms of B-cells of macroglobulinemia and MM. Recent reports of the existence of T-rAcP activity in the neoplastic cells from the patients with prolymphocytic leukemia [19], B-CLL [20], and Sezary syndrome (211 may be compatible with our results.…”
Section: Discussionsupporting
confidence: 93%
“…These results seem to indicate that T-rAcP is observed in well-differentiated lymphoid cells except the most highly differentiated forms of B-cells of macroglobulinemia and MM. Recent reports of the existence of T-rAcP activity in the neoplastic cells from the patients with prolymphocytic leukemia [19], B-CLL [20], and Sezary syndrome (211 may be compatible with our results.…”
Section: Discussionsupporting
confidence: 93%
“…These varying results are in accordance with findings of other authors [3,6,14] who observed typical cases of PL with either B-or T-ceU characteristics. These varying results are in accordance with findings of other authors [3,6,14] who observed typical cases of PL with either B-or T-ceU characteristics.…”
Section: Discussionsupporting
confidence: 93%
“…PL can be delimitated from CLL, from ALL, and from lymphosarcoma cell leukemia mainly on the grounds of typical clinical (greatly enlarged spleen) and hematological (very high leukocyte counts and peculiar morphology of leukemic cells) findings. PL, as described by Galton [5,6] and confirmed by other authors [4,11,14], appears to be quite rare. In PL, the response to treatment usually effective in classical CLL or ALL is almost uniformly poor, the survival time is in the range of several months and only few patients survive for more than one year after diagnosis [6].…”
Section: Discussionsupporting
confidence: 64%
“…In total, 6 cases of T-PL (Catovsky et a1 1973, Brouet et a1 1975, Loffler et al 1977, Lennert et al 1978, Abbrederis et a1 1979 and 16 cases of B-PL (Catovsky et a1 1973, Buskard et a1 1976, Catovsky 1977, Lennert et a1 1978, Abbrederis et al 1979 have been reported. In total, 6 cases of T-PL (Catovsky et a1 1973, Brouet et a1 1975, Loffler et al 1977, Lennert et al 1978, Abbrederis et a1 1979 and 16 cases of B-PL (Catovsky et a1 1973, Buskard et a1 1976, Catovsky 1977, Lennert et a1 1978, Abbrederis et al 1979 have been reported.…”
Section: Discussionmentioning
confidence: 99%